JAK inhibition therapy for intractable cutaneous infectious granulomatosis with unknown etiology: a case report
This case-report highlights a potential role for JAK inhibition, upadacitinib, in managing refractory cutaneous granulomatosis with an excessive immune response despite no identifiable pathogen and pathogen clearance.
Authors
- H Liu
- F. Zhang
- Suiting Ao (ORCID: https://orcid.org/0009-0008-0661-1765)
- Fanli Xu
- Mingjia Hu
- Shuang Lyv
Institutions
- Academy of Medical Sciences (GB)
- Shandong Provincial Institute of Dermatology and Venereology (CN)
- Shandong First Medical University (CN)
Publication Details
- Journal
- Journal of Dermatological Treatment
- Published
- 2026-03-13
- DOI
- https://doi.org/10.1080/09546634.2026.2637510
- Primary Topic
- Sarcoidosis and Beryllium Toxicity Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00